Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

Elizabeth Nicole Da Silva^*, Katrina Louise Randall

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

41 Citations (Scopus)

Original language	English
Pages (from-to)	687-688
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	1
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2013.07.004
Publication status	Published - Nov 2013

Access to Document

@article{1e26ea69f7c44055ae2fdb968e4a4fe1,

title = "Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome",

author = "{Da Silva}, {Elizabeth Nicole} and Randall, {Katrina Louise}",

year = "2013",

month = nov,

doi = "10.1016/j.jaip.2013.07.004",

language = "English",

volume = "1",

pages = "687--688",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "6",

}

TY - JOUR

T1 - Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

AU - Da Silva, Elizabeth Nicole

AU - Randall, Katrina Louise

PY - 2013/11

Y1 - 2013/11

UR - http://www.scopus.com/inward/record.url?scp=84887017741&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2013.07.004

DO - 10.1016/j.jaip.2013.07.004

M3 - Article

SN - 2213-2198

VL - 1

SP - 687

EP - 688

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -